Tag - TNG

Developments

Transgene and ProBioGen partner to advance cancer vaccine development

Transgene (Euronext Paris:TNG) announced a licensing agreement with closely-held CDMO, ProBioGen, for the AGE1.CR.pIX suspension cell line. The companies seek to add value by partnering to combine ProBioGen’s specific...

November 5, 2024

Markets

Cantor starts Transgene at OW; PT €4

Cantor Fitzgerald launch coverage of France-based Transgene (TNG:PA) with an “overweight” rating and a 12-month price target of €4. The stock was quoted at €2.01 on Feb. 17. “Our constructive view on Transgene stock is...

February 17, 2023

Tag - TNG

Transgene and ProBioGen partner to advance cancer vaccine development

Cantor starts Transgene at OW; PT €4

General

More